| Product NDC: | 64125-117 |
| Proprietary Name: | Furosemide |
| Non Proprietary Name: | Furosemide |
| Active Ingredient(s): | 40 mg/1 & nbsp; Furosemide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64125-117 |
| Labeler Name: | Excellium Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077293 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060201 |
| Package NDC: | 64125-117-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (64125-117-01) |
| NDC Code | 64125-117-01 |
| Proprietary Name | Furosemide |
| Package Description | 100 TABLET in 1 BOTTLE (64125-117-01) |
| Product NDC | 64125-117 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Furosemide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20060201 |
| Marketing Category Name | ANDA |
| Labeler Name | Excellium Pharmaceutical Inc. |
| Substance Name | FUROSEMIDE |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |